David Johnstone, MD

Publications

• Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial.

  (Criner GJ, Delage A, Voelker K, Hogarth DK, Majid A, Zgoda M, Lazarus DR, Casal R, Benzaquen SB, Holladay RC, Wellikoff A, Calero K, Rumbak MJ, Branca PR, Abu-Hijleh M, Mallea JM, Kalhan R, Sachdeva A, Kinsey CM, Lamb CR, Reed MF, Abouzgheib WB, Kaplan PV, Marrujo GX, Johnstone DW, Gasparri MG, Meade AA, Hergott CA, Reddy C, Mularski RA, Case AH, Makani SS, Shepherd RW, Chen B, Holt GE, Martel S.) Am J Respir Crit Care Med. 2019 Dec 01;200(11):1354-1362 PMID: 31365298 PMCID: PMC6884033 SCOPUS ID: 2-s2.0-85075813055 08/01/2019

• Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer.

  (Timmerman RD, Hu C, Michalski JM, Bradley JC, Galvin J, Johnstone DW, Choy H.) JAMA Oncol. 2018 Sep 01;4(9):1287-1288 PMID: 29852036 PMCID: PMC6117101 SCOPUS ID: 2-s2.0-85053299313 06/01/2018

• Atrial fibrillation after transhiatal esophagectomy with transcervical endoscopic esophageal mobilization: one institution's experience.

  (Colwell EM, Encarnacion CO, Rein LE, Szabo A, Haasler G, Gasparri M, Tisol W, Johnstone D.) J Cardiothorac Surg. 2018 Jun 19;13(1):73 PMID: 29921284 PMCID: PMC6007001 SCOPUS ID: 2-s2.0-85048791354 06/21/2018

• CT Screening for Lung Cancer: How to Fulfill the Promise.

  (Johnstone DW.) Oncology (Williston Park). 2015 Dec;29(12):950-1 PMID: 26676899 SCOPUS ID: 2-s2.0-84951116451 12/18/2015

• Outcomes in thoracic surgical management of non-small cell lung cancer.

  (Wyler von Ballmoos MC, Johnstone DW.) J Surg Oncol. 2014 Oct;110(5):539-42 PMID: 25171225 SCOPUS ID: 2-s2.0-84921709022 08/30/2014

• Drinking water treatment is not associated with an observed increase in neural tube defects in mice.

  (Melin VE, Johnstone DW, Etzkorn FA, Hrubec TC.) Environ Monit Assess. 2014 Jun;186(6):3717-24 PMID: 24497082 PMCID: PMC5904835 02/06/2014

• Negative predictive value (NPV) of FDG PET-CT for nodal disease in clinically node-negative early stage lung cancer (AJCC 7th ed T1-2aN0) and identification of risk factors for occult nodal (pN1-N2) metastasis: Implications for SBRT

  (Paravati AJ, Johnstone DW, Seltzer MA, Johnstone CA.) Translational Cancer Research. 1 August 2014;3(4):313-319 SCOPUS ID: 2-s2.0-84962713842 08/01/2014

• Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer.

  (Ma T, Galimberti F, Erkmen CP, Memoli V, Chinyengetere F, Sempere L, Beumer JH, Anyang BN, Nugent W, Johnstone D, Tsongalis GJ, Kurie JM, Li H, Direnzo J, Guo Y, Freemantle SJ, Dragnev KH, Dmitrovsky E.) Mol Cancer Ther. 2013 Aug;12(8):1545-55 PMID: 23686769 PMCID: PMC3742691 SCOPUS ID: 2-s2.0-84882267461 05/21/2013

• Postpneumonectomy syndrome

  (Hoenig MR, Johnstone DW.) Cardiothoracic Surgery Review. 5 January 2012:1076-1078 SCOPUS ID: 2-s2.0-84976548322 01/05/2012

• Mediastinoscopy

  (Goldberg JB, Johnstone DW.) Cardiothoracic Surgery Review. 5 January 2012:960-961 SCOPUS ID: 2-s2.0-84976539074 01/05/2012

• Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models.

  (Dragnev KH, Ma T, Cyrus J, Galimberti F, Memoli V, Busch AM, Tsongalis GJ, Seltzer M, Johnstone D, Erkmen CP, Nugent W, Rigas JR, Liu X, Freemantle SJ, Kurie JM, Waxman S, Dmitrovsky E.) Cancer Prev Res (Phila). 2011 Jun;4(6):818-28 PMID: 21636548 PMCID: PMC3108499 SCOPUS ID: 2-s2.0-79957860099 06/04/2011

• Anatomy of the thoracic duct and chylothorax

  (Johnstone DW.) General Thoracic Surgery: Seventh Edition. 21 December 2011;1-2:2211-2231 SCOPUS ID: 2-s2.0-85052974166 12/21/2011